Yi Chu1, Donald D Lund1, Hardik Doshi1, Henry L Keen1, Kevin L Knudtson1, Nathan D Funk1, Jian Q Shao1, Justine Cheng1, Georges P Hajj1, Kathy A Zimmerman1, Melissa K Davis1, Robert M Brooks1, Mark W Chapleau1, Curt D Sigmund1, Robert M Weiss1, Donald D Heistad2. 1. From the Departments of Internal Medicine (Y.C., D.D.L., H.D., N.D.F., J.C., G.P.H., K.A.Z., M.K.D., R.M.B., M.W.C., R.M.W., D.D.H.), Pharmacology (H.L.K., C.D.S., D.D.H.), Molecular Physiology and Biophysics (M.W.C.), Central Microscopy Research Facility (J.Q.S.), Iowa Institute of Human Genetics Genomics Division (K.L.K.), University of Iowa Carver College of Medicine, Iowa City; Veterans Administration Medical Center, Iowa City (M.W.C.); and Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder (D.D.H.). 2. From the Departments of Internal Medicine (Y.C., D.D.L., H.D., N.D.F., J.C., G.P.H., K.A.Z., M.K.D., R.M.B., M.W.C., R.M.W., D.D.H.), Pharmacology (H.L.K., C.D.S., D.D.H.), Molecular Physiology and Biophysics (M.W.C.), Central Microscopy Research Facility (J.Q.S.), Iowa Institute of Human Genetics Genomics Division (K.L.K.), University of Iowa Carver College of Medicine, Iowa City; Veterans Administration Medical Center, Iowa City (M.W.C.); and Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder (D.D.H.). donald-heistad@uiowa.edu.
Abstract
OBJECTIVE: Hypercholesterolemia and hypertension are associated with aortic valve stenosis (AVS) in humans. We have examined aortic valve function, structure, and gene expression in hypercholesterolemic/hypertensive mice. APPROACH AND RESULTS: Control, hypertensive, hypercholesterolemic (Apoe(-/-)), and hypercholesterolemic/hypertensive mice were studied. Severe aortic stenosis (echocardiography) occurred only in hypercholesterolemic/hypertensive mice. There was minimal calcification of the aortic valve. Several structural changes were identified at the base of the valve. The intercusp raphe (or seam between leaflets) was longer in hypercholesterolemic/hypertensive mice than in other mice, and collagen fibers at the base of the leaflets were reoriented to form a mesh. In hypercholesterolemic/hypertensive mice, the cusps were asymmetrical, which may contribute to changes that produce AVS. RNA sequencing was used to identify molecular targets during the developmental phase of stenosis. Genes related to the structure of the valve were identified, which differentially expressed before fibrotic AVS developed. Both RNA and protein of a profibrotic molecule, plasminogen activator inhibitor 1, were increased greatly in hypercholesterolemic/hypertensive mice. CONCLUSIONS: Hypercholesterolemic/hypertensive mice are the first model of fibrotic AVS. Hypercholesterolemic/hypertensive mice develop severe AVS in the absence of significant calcification, a feature that resembles AVS in children and some adults. Structural changes at the base of the valve leaflets include lengthening of the raphe, remodeling of collagen, and asymmetry of the leaflets. Genes were identified that may contribute to the development of fibrotic AVS.
OBJECTIVE:Hypercholesterolemia and hypertension are associated with aortic valve stenosis (AVS) in humans. We have examined aortic valve function, structure, and gene expression in hypercholesterolemic/hypertensivemice. APPROACH AND RESULTS: Control, hypertensive, hypercholesterolemic (Apoe(-/-)), and hypercholesterolemic/hypertensivemice were studied. Severe aortic stenosis (echocardiography) occurred only in hypercholesterolemic/hypertensivemice. There was minimal calcification of the aortic valve. Several structural changes were identified at the base of the valve. The intercusp raphe (or seam between leaflets) was longer in hypercholesterolemic/hypertensivemice than in other mice, and collagen fibers at the base of the leaflets were reoriented to form a mesh. In hypercholesterolemic/hypertensivemice, the cusps were asymmetrical, which may contribute to changes that produce AVS. RNA sequencing was used to identify molecular targets during the developmental phase of stenosis. Genes related to the structure of the valve were identified, which differentially expressed before fibrotic AVS developed. Both RNA and protein of a profibrotic molecule, plasminogen activator inhibitor 1, were increased greatly in hypercholesterolemic/hypertensivemice. CONCLUSIONS:Hypercholesterolemic/hypertensivemice are the first model of fibrotic AVS. Hypercholesterolemic/hypertensivemice develop severe AVS in the absence of significant calcification, a feature that resembles AVS in children and some adults. Structural changes at the base of the valve leaflets include lengthening of the raphe, remodeling of collagen, and asymmetry of the leaflets. Genes were identified that may contribute to the development of fibrotic AVS.
Authors: David Messika-Zeitoun; Marie-Christine Aubry; Delphine Detaint; Lawrence F Bielak; Patricia A Peyser; Patrick F Sheedy; Stephen T Turner; Jerome F Breen; Christopher Scott; A Jamil Tajik; Maurice Enriquez-Sarano Journal: Circulation Date: 2004-07-12 Impact factor: 29.690
Authors: Lee Joseph; Amar Krishnaswamy; E Murat Tuzcu; Abraham Sonny; Alper Ozkan; Lars G Svensson; Brian P Griffin; James Thomas; Samir R Kapadia Journal: J Heart Valve Dis Date: 2014-07
Authors: Ramzi N El Accaoui; Sarah T Gould; Georges P Hajj; Yi Chu; Melissa K Davis; Diane C Kraft; Donald D Lund; Robert M Brooks; Hardik Doshi; Kathy A Zimmerman; William Kutschke; Kristi S Anseth; Donald D Heistad; Robert M Weiss Journal: Am J Physiol Heart Circ Physiol Date: 2014-03-07 Impact factor: 4.733
Authors: Ratnasari Padang; Richard D Bagnall; Tatiana Tsoutsman; Paul G Bannon; Christopher Semsarian Journal: Physiol Genomics Date: 2014-12-29 Impact factor: 3.107
Authors: Yi Chu; Donald D Lund; Robert M Weiss; Robert M Brooks; Hardik Doshi; Georges P Hajj; Curt D Sigmund; Donald D Heistad Journal: Arterioscler Thromb Vasc Biol Date: 2013-01-03 Impact factor: 8.311
Authors: Jordan D Miller; Robert M Weiss; Kristine M Serrano; Robert M Brooks; Christopher J Berry; Kathy Zimmerman; Stephen G Young; Donald D Heistad Journal: Circulation Date: 2009-05-11 Impact factor: 29.690
Authors: Kevin Monaghan; Jennifer McNaughten; Mary K McGahon; Catriona Kelly; Daniel Kyle; Phaik Har Yong; J Graham McGeown; Tim M Curtis Journal: PLoS One Date: 2015-06-05 Impact factor: 3.240
Authors: Brian A Aguado; Cierra J Walker; Joseph C Grim; Megan E Schroeder; Dilara Batan; Brandon J Vogt; Andrea Gonzalez Rodriguez; Jessica A Schwisow; Karen S Moulton; Robert M Weiss; Donald D Heistad; Leslie A Leinwand; Kristi S Anseth Journal: Circulation Date: 2022-01-10 Impact factor: 29.690
Authors: Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311
Authors: Carolyn M Roos; Bin Zhang; Michael A Hagler; Grace C Verzosa; Runqing Huang; Elise A Oehler; Arman Arghami; Jordan D Miller Journal: Front Cardiovasc Med Date: 2021-06-24
Authors: Robert M Weiss; Yi Chu; Robert M Brooks; Donald D Lund; Justine Cheng; Kathy A Zimmerman; Melissa K Kafa; Phanicharan Sistla; Hardik Doshi; Jian Q Shao; Ramzi N El Accaoui; Catherine M Otto; Donald D Heistad Journal: J Am Heart Assoc Date: 2018-06-30 Impact factor: 5.501
Authors: Zhongli Chen; Ying Shen; Qiqi Xue; Bo Wen Lin; Xiao Yan He; Yi Bo Zhang; Ying Yang; Wei Feng Shen; Ye Hong Liu; Ke Yang Journal: Front Cardiovasc Med Date: 2020-10-14